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AUTHOR'S REPLY Dr Lenox-Smith's observations are correct concerning the use of sulphamethoxypyridazine in urinary tract infections, for which it is no longer licensed, but they do not apply to bullous skin diseases. For over 30 years it has been prescribed in dermatitis herpetiformis.' It is also used, on a named patient basis, in linear IgA disease, which is an intensely pruritic condition. Dose is titrated against clinical response and, in Oxford, there are 12 patients receiving doses of up to 1 5 g of this drug daily with good effect. It is commonly given when a patient is intolerant of dapsone. The alternative is sulphapyridine, which causes nausea and is associated with renal failure and agranulocytosis. The main purpose of our letter and of the article by Dr C L Steinfort and others (April 1989; 44:310-1) was to report the alveolitis, which is a previously undetected but serious complication of sulphamethoxypyridazine. As we suggested, routine three monthly spirometry and chest radiography may be indicated in patients receiving sulphamethoxypyridazine.
The final point ofDr Lenox-Smith's letter, concerning dosage interval, is entirely correct. The stated regimen in our letter is inadvertently incorrect and the patient actually received a once daily dose. Despite the seemingly high specificity of ANCA for certain diseases, their exact role is unclear. It might be a pathogenetic factor responsible for tissue injury or, alternatively, might simply be an epiphenomenon resulting from the increased leucocyte turnover, which has been shown to occur in systemic vasculitides.' To further address this issue we tested for the presence ofANCA in a group of patients who had lymphoproliferative diseases and had reduced leucocyte counts resulting from chemotherapy.
JS
Serum samples from 18 patients, 10 male and eight female, ranging in age from 15 months to 81 years (median 39 years), were tested for presence of ANCA by indirect fluorescence as previously described.2 Nine patients had leukaemia, five multiple myeloma, three lymphoma, and one polycythaemia vera. Pretreatment leucocyte counts ranged from 4 0 to 26-0 (mean 31 8) x 109 cells/l and post-treatment lowest counts ranged from 0 1 to 3 2 (mean 2 1)
x 109 cells/l. Serum from all patients was negative for ANCA, in contrast to the serum from our positive control subjects.
Thus patients with significant destruction and turnover of leucocytes do not appear to produce ANCA, strengthening the theory that these antibodies may be responsible for the pathological lesions in Wegener's granulomatosis, possibly by activating neutrophils, rather than simply being a response to neutrophil destruction. Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects
We read with interest the paper by Dr P Black et al (June 1989; 44:491-5) and would like to support their findings with our own observations in the dog. ' We measured the change in airway responsiveness to methacholine and the cell content of bronchoalveolar lavage fluid one, three, and six hours after administration of aerosolised leukotriene (LT)B4 (10 sg) to beagle dogs. In contrast to previous reports in the dog,2 we found that airway responsiveness was reduced after LTB4 administration at each time point, despite a threefold increase in lavage fluid neutrophils.
These results show that the recruitment of neutrophils to the airways did not cause a concomitant increase in airway responsiveness to methacholine. The mechanism by which LTB4 reduces airway responsiveness is unknown. A similar result has been reported in the guinea pig. 
Pulmonary eosinophilia
In the study reported in the two articles on pulmonary eosinophilia published in November' 33 patients met the criteria for allergic bronchopulmonary aspergillosis and 32 were labelled as having "non-allergic bronchopulmonary aspergillosis" (the latter an unfortunate misnomer). The subsequent comparison of these two groups in respect of clinical and haematological features, response to prednisolone, and prognosis assumed a common pathological basis within each group, which neither in fact possessed. The weakness of that assumption is reflected in the negative nomenclature of the "non"allergic bronchopulmonary aspergillosis group, and the authors themselves admit that this group "may be associated with several different syndromes whose underlying pathogeneses remain unclear." At first sight it might seem reasonable for the authors to assume that patients who met the criteria for allergic bronchopulmonary aspergillosis, unlike those in the other group, did indeed have disease with a common pathological basis, but that too is open to question. Pathological differences within that group could have been recognised, or at least suspected, from the nature of the radiological
